PMD is number 85 for the largest percentage gain out of 100

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Waveform's Grand Entry: A New Era in Cannabis Distribution Ever feel like the cannabis game needed a serious shake-up? Well, it's here. At the intersection of technology and distribution stands Waveform, the newly minted name for the company born from the merger of Kiva Sales & Service (KSS) and Petalfast. Underpinning this powerhouse is a tech-forward approach that's as...

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

AIIB's Strategic Move: Fund Enhancement I'm sitting here digesting the latest AIIB news over black coffee, and you can feel the tremors in the infrastructure world. The Asian Infrastructure Investment Bank (AIIB) just cranked up its Project Preparation Special Fund with a fresh shot of USD83.5 million. That's in addition to what’s already cooked up about USD213 million...

Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...

Medicare's CJR-X Challenges Hospitals 2028 is setting up to be a year hospitals across the U.S. remember, not with a smile, but likely with clenched teeth. Medicare's CJR-X model is ready to put about 2,217 hospitals in a financial vise over hip, knee, and ankle replacements. Going into effect on January 1, 2028, this mandate turns health networks' profit dreams into a...

Centric Software Steps Into the Ice Cream Game Revolutionizing the digital landscape of The Magnum Ice Cream Company (TMICC), Centric Software has been called to the plate to drive transformation in this global ice cream behemoth. With operations in over 80 countries and a portfolio as diverse as your neighborhood freezer section, TMICC's collaboration with Centric is set...

What Went Awry with Everest Group? Alright, folks, let's chew through the latest stock rumble hitting the wires: Everest Group, Ltd. (NYSE: EG) has a hefty class-action lawsuit tossed its way, courtesy of DJS Law Group. Now, if you're scratching your head trying to piece this together, you're not alone. This isn't just some minor hiccup; we're talking allegations of...

CPQ Tech: Unpacking the 2026 Manufacturing Landscape In the cutthroat world of manufacturing, it's adapt or die. Right now, happens it's the fixers in Configure, Price, Quote (CPQ) technology, stepping in to save the day. Nucleus Research just dropped their 2026 Manufacturing CPQ Technology Value Matrix, shining a bright spotlight on who’s leading the pack and why it...

What's Roaring: The Latest from KOVE Anybody who’s been following motorcycle trends knows that EICMA 2026 was destined to be a spectacle, and KOVE didn’t disappoint. They rolled out a fleet of five new models, including the 125 RALLY, 350 RALLY, 650RR, and two head-turners on the electric front: the BONIC and the E-500RR. Each model brings something fresh to the...

SEATOM's Selection for NATO's Accelerator Programme Today, SEATOM announced a significant milestone as it was chosen to participate in the NATO Defence Innovation Accelerator for the North Atlantic (DIANA) 2026 Challenge Programme. This prestigious selection underscores SEATOM's innovative approach to developing nuclear technology tailored for maritime and extreme...

OpenAI Completes a Major Acquisition OpenAI has recently wrapped up a remarkable deal by acquiring Jony Ive's AI hardware startup, io Products, for a staggering $6.5 billion. This acquisition brings the design genius, renowned for his work at a major tech giant, into OpenAI's fold to help create a new generation of smart devices. Key Developments Post-Acquisition The...

Opportunities for KinderCare Investors Robbins Geller Rudman & Dowd LLP has announced a significant opportunity for investors of KinderCare Learning Companies, Inc. (NYSE: KLC) who have experienced substantial losses. This is a pivotal moment for shareholders as they can now seek to lead a class action lawsuit against the company. Understanding the Class Action Lawsuit...

Growth of Baltic Horizon Fund's NAV in May 2025 The Baltic Horizon Fund reported an increase in its net asset value (NAV) per unit, which rose to EUR 0.6757 at the close of May 2025. This figure represents a slight gain from the NAV of EUR 0.6740 recorded at the end of April 2025. The fund's overall net asset value reached EUR 97.0 million, up from EUR 96.8 million in the...

Autolus Therapeutics Showcases CARLYSLE Trial Results Autolus Therapeutics plc (Nasdaq: AUTL), a biopharmaceutical leader in developing innovative T cell therapies, recently showcased promising preliminary data from the CARLYSLE trial, which focuses on severe refractory systemic lupus erythematosus (srSLE). The data were presented during a special session at a leading...